CHF 978.56
(0.57%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 26.61 CHF | -28.22% |
2022 | 37.07 CHF | 63.09% |
2021 | 22.73 CHF | 54.84% |
2020 | 14.68 CHF | 14.24% |
2019 | 12.85 CHF | -4.96% |
2018 | 13.52 CHF | 31.52% |
2017 | 10.28 CHF | 43.18% |
2016 | 7.18 CHF | -27.4% |
2015 | 9.89 CHF | -0.8% |
2014 | 9.97 CHF | -33.84% |
2013 | 15.07 CHF | 161.63% |
2012 | 5.76 CHF | 118.18% |
2011 | 2.64 CHF | 154.89% |
2010 | -4.81 CHF | 62.39% |
2009 | -12.79 CHF | 52.63% |
2008 | -27.00 CHF | -250.08% |
2007 | 17.99 CHF | 53.76% |
2006 | 11.70 CHF | -11.56% |
2005 | 13.23 CHF | 120.13% |
2004 | 6.01 CHF | -69.24% |
2003 | 19.54 CHF | -5.6% |
2002 | 20.70 CHF | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 16.73 CHF | 0.0% |
2023 Q2 | 13.00 CHF | 0.0% |
2023 FY | - CHF | -28.22% |
2023 Q4 | 13.56 CHF | 0.0% |
2022 Q2 | 14.85 CHF | 0.0% |
2022 Q4 | 22.22 CHF | 0.0% |
2022 FY | - CHF | 63.09% |
2021 Q4 | 15.75 CHF | 0.0% |
2021 Q2 | 6.97 CHF | 0.0% |
2021 FY | - CHF | 54.84% |
2020 Q2 | 5.00 CHF | 0.0% |
2020 FY | - CHF | 14.24% |
2020 Q4 | 9.61 CHF | 0.0% |
2019 Q4 | 5.38 CHF | 0.0% |
2019 FY | - CHF | -4.96% |
2019 Q2 | 7.47 CHF | 0.0% |
2018 FY | - CHF | 31.52% |
2018 Q2 | 6.86 CHF | 0.0% |
2018 Q4 | 6.24 CHF | 0.0% |
2017 Q4 | 4.74 CHF | 0.0% |
2017 Q2 | 5.10 CHF | 0.0% |
2017 FY | - CHF | 43.18% |
2016 Q4 | 3.48 CHF | 0.0% |
2016 FY | - CHF | -27.4% |
2016 Q2 | 3.56 CHF | 0.0% |
2015 Q4 | 4.76 CHF | 0.0% |
2015 Q2 | 5.00 CHF | 0.0% |
2015 FY | - CHF | -0.8% |
2014 Q2 | 5.01 CHF | 0.0% |
2014 FY | - CHF | -33.84% |
2014 Q4 | 4.91 CHF | 0.0% |
2013 FY | - CHF | 161.63% |
2013 Q4 | 8.64 CHF | 0.0% |
2013 Q2 | 4.93 CHF | 0.0% |
2012 FY | - CHF | 118.18% |
2012 Q4 | 3.43 CHF | 146.76% |
2012 Q3 | 1.39 CHF | 0.0% |
2012 Q2 | 1.39 CHF | 0.0% |
2012 Q1 | 1.39 CHF | 0.0% |
2011 Q3 | 0.64 CHF | 0.0% |
2011 Q2 | 0.64 CHF | 0.0% |
2011 Q1 | 0.64 CHF | 0.0% |
2011 FY | - CHF | 154.89% |
2011 Q4 | 1.39 CHF | 117.19% |
2010 FY | - CHF | 62.39% |
2010 Q4 | 0.64 CHF | 306.45% |
2010 Q3 | -0.31 CHF | 0.0% |
2010 Q2 | -0.31 CHF | 0.0% |
2010 Q1 | -0.31 CHF | 0.0% |
2009 Q2 | -3.20 CHF | 0.0% |
2009 Q4 | -0.31 CHF | 90.31% |
2009 FY | - CHF | 52.63% |
2009 Q3 | -3.20 CHF | 0.0% |
2009 Q1 | -3.20 CHF | 0.0% |
2008 Q2 | -6.75 CHF | 0.0% |
2008 Q4 | -3.20 CHF | 52.59% |
2008 FY | - CHF | -250.08% |
2008 Q3 | -6.75 CHF | 0.0% |
2008 Q1 | -6.75 CHF | 0.0% |
2007 Q3 | 2.02 CHF | 0.0% |
2007 FY | - CHF | 53.76% |
2007 Q4 | -6.75 CHF | -434.16% |
2007 Q2 | 2.02 CHF | 0.0% |
2007 Q1 | 2.02 CHF | 0.0% |
2006 Q2 | 2.02 CHF | 0.0% |
2006 Q1 | 2.02 CHF | 0.0% |
2006 FY | - CHF | -11.56% |
2006 Q4 | 2.02 CHF | 0.0% |
2006 Q3 | 2.02 CHF | 0.0% |
2005 FY | - CHF | 120.13% |
2005 Q4 | 2.02 CHF | -38.97% |
2005 Q2 | 3.31 CHF | 0.0% |
2005 Q1 | 3.31 CHF | 0.0% |
2005 Q3 | 3.31 CHF | 0.0% |
2004 FY | - CHF | -69.24% |
2004 Q1 | 1.50 CHF | 0.0% |
2004 Q2 | 1.50 CHF | 0.0% |
2004 Q3 | 1.50 CHF | 0.0% |
2004 Q4 | 3.31 CHF | 120.67% |
2003 Q3 | 4.90 CHF | 0.0% |
2003 Q2 | 4.90 CHF | 0.0% |
2003 FY | - CHF | -5.6% |
2003 Q4 | 1.50 CHF | -69.39% |
2003 Q1 | 4.90 CHF | 0.0% |
2002 Q1 | 5.14 CHF | 0.0% |
2002 Q2 | 5.14 CHF | 0.0% |
2002 FY | - CHF | 0.0% |
2002 Q3 | 5.14 CHF | 0.0% |
2002 Q4 | 4.90 CHF | -4.67% |
2001 Q4 | 5.14 CHF | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Relief Therapeutics Holding AG | -8.35 CHF | 418.683% |
Tecan Group AG | 10.34 CHF | -157.35% |
Santhera Pharmaceuticals Holding AG | 5.18 CHF | -413.707% |
Basilea Pharmaceutica AG | 0.87 CHF | -2958.621% |
Bachem Holding AG | 1.50 CHF | -1674.0% |
Molecular Partners AG | -1.89 CHF | 1507.937% |